Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y <sub>12</sub> Antagonist, With Clopidogrel in Percutaneous Coronary Intervention

D. Wiviott, Stephen; M. Antman, Elliott; J. Winters, Kenneth; J. Weerakkody, Govinda; A. Murphy, Sabina; D. Behounek, Bruce; J. Carney, Robert; Lazzam, Charles; G. McKay, Raymond; H. McCabe, Carolyn; Braunwald, Eugene

doi:10.1161/circulationaha.104.502815

Public

Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y 12 Antagonist, With Clopidogrel in Percutaneous Coronary Intervention

Published in Circulation • Jun 21, 2005

Authors:

Stephen D. Wiviott

Elliott M. Antman

Kenneth J. Winters

Abstract

BACKGROUND: Despite the current standard antiplatelet regimen of aspirin and clopidogrel (with or without glycoprotein IIb/IIIa inhibitors) in percutaneous coronary intervention patients, periprocedural and postprocedural ischemic events continue to occur. Prasugrel (CS-747, LY640315), a novel poten...

Subject

Prasugrel

Medicine

Clopidogrel

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!